{"id":396029,"date":"2026-04-16T23:21:17","date_gmt":"2026-04-16T23:21:17","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/396029\/"},"modified":"2026-04-16T23:21:17","modified_gmt":"2026-04-16T23:21:17","slug":"why-revolution-medicines-rvmd-still-looks-like-a-prime-takeover-target-after-daraxonrasib-data","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/396029\/","title":{"rendered":"Why Revolution Medicines (RVMD) Still Looks Like a Prime Takeover Target After Daraxonrasib Data"},"content":{"rendered":"\n

Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the 10 potential takeover targets with strong price momentum<\/a>. The appeal is not hard to see. The company is built around RAS-targeted oncology, and their daraxonrasib has become one of the most closely watched assets in that space.<\/p>\n

The stock\u2019s momentum has only strengthened the strategic case. Barron\u2019s reported on April 13 that Revolution Medicines shares had already gained 164% over the prior year before jumping another 39% that day after new trial data.<\/p>\n

\"Why Why Revolution Medicines (RVMD) Still Looks Like a Prime Takeover Target After Daraxonrasib Data <\/p>\n

Pressmaster\/Shutterstock.com<\/p>\n

The catalyst was daraxonrasib\u2019s pivotal Phase 3 RASolute 302 result announced on April 13, 2026. Reuters reported that the drug helped previously treated metastatic pancreatic cancer patients live a median of 13.2 months, compared with 6.7 months for standard chemotherapy, while also improving progression-free survival. RBC said the drug could eventually generate more than $5 billion in U.S. sales.<\/p>\n

Daraxonrasib\u2019s strategic value had already drawn takeover attention. On January 8, 2026, Reuters reported that Merck was in talks to buy Revolution Medicines in a deal that could value the company at $28 billion to $32 billion. Earlier, the Wall Street Journal had reported AbbVie was near a deal, though AbbVie denied it to Reuters the next day. Later in January, Reuters reported that Merck was no longer in talks, but said another buyer could still emerge.<\/p>\n

Revolution Medicines, Inc. (NASDAQ:RVMD) is a late-stage clinical oncology company focused on developing targeted therapies for patients with RAS-addicted cancers.<\/p>\n

While we acknowledge the potential of RVMD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock<\/a>.<\/p>\n

READ NEXT: 33 Stocks That Should Double in 3 Years<\/a> and 15 Stocks That Will Make You Rich in 10 Years<\/a>.<\/p>\n

Disclosure: None. Follow Insider Monkey on Google News<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the 10 potential takeover targets with strong price momentum. The appeal…\n","protected":false},"author":2,"featured_media":396030,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[163,85,46,482,51429],"class_list":["post-396029","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-health","tag-il","tag-israel","tag-medication","tag-price-momentum"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/396029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=396029"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/396029\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/396030"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=396029"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=396029"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=396029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}